bond.life

bond.life sells science-backed longevity supplements, at-home diagnostic kits, and a members-only digital health-coaching platform. SKUs fall in the premium tier: single-month supplement stacks start around US $99, while the full annual diagnostics-plus-coaching program tops US $1,200. Everything is ordered direct-to-consumer through bond.life; no retail partners or Amazon storefront exist. The company formulates around its “Longevity Matrix,” a patent-pending combination of NAD+ precursors, senolytics, and AMPK activators dosed to match human trials cited on product pages. Every batch is third-party tested for purity, and results of those tests are posted as downloadable COAs—uncommon transparency in the category. bond.life also bundles blood, epigenetic, and microbiome tests that feed an AI dashboard translating biomarker shifts into personalized dosing and lifestyle prompts. Core buyers are 30-55-year-old tech professionals who already track sleep, HRV, and glucose and want an evidence-based upgrade path to “slow aging.” They value data ownership (raw lab files can be exported), dislike celebrity nootropics hype, and are willing to pre-pay annually for concierge access to the brand’s in-house MDs and PhDs. bond.life competes with high-end supplement subscription services and functional-medicine tele-clinics. It differentiates by integrating testing, formulation, and coaching inside one vertically controlled stack, eliminating the need to juggle separate lab companies, pill brands, and wellness apps.